跳转至内容

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

For important updates on recent policy changes, please click here for more details.

Merck
CN
  • A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.

A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.

Immunity (2018-03-20)
Tongqing Zhou, Anqi Zheng, Ulrich Baxa, Gwo-Yu Chuang, Ivelin S Georgiev, Rui Kong, Sijy O'Dell, Syed Shahzad-Ul-Hussan, Chen-Hsiang Shen, Yaroslav Tsybovsky, Robert T Bailer, Syna K Gift, Mark K Louder, Krisha McKee, Reda Rawi, Catherine H Stevenson, Guillaume B E Stewart-Jones, Justin D Taft, Eric Waltari, Yongping Yang, Baoshan Zhang, Sachin S Shivatare, Vidya S Shivatare, Chang-Chun D Lee, Chung-Yi Wu, James C Mullikin, Carole A Bewley, Dennis R Burton, Victoria R Polonis, Lawrence Shapiro, Chi-Huey Wong, John R Mascola, Peter D Kwong, Xueling Wu
摘要

Virtually the entire surface of the HIV-1-envelope trimer is recognized by neutralizing antibodies, except for a highly glycosylated region at the center of the "silent face" on the gp120 subunit. From an HIV-1-infected donor, #74, we identified antibody VRC-PG05, which neutralized 27% of HIV-1 strains. The crystal structure of the antigen-binding fragment of VRC-PG05 in complex with gp120 revealed an epitope comprised primarily of N-linked glycans from N262, N295, and N448 at the silent face center. Somatic hypermutation occurred preferentially at antibody residues that interacted with these glycans, suggesting somatic development of glycan recognition. Resistance to VRC-PG05 in donor #74 involved shifting of glycan-N448 to N446 or mutation of glycan-proximal residue E293. HIV-1 neutralization can thus be achieved at the silent face center by glycan-recognizing antibody; along with other known epitopes, the VRC-PG05 epitope completes coverage by neutralizing antibody of all major exposed regions of the prefusion closed trimer.

材料
货号
品牌
产品描述

Sigma-Aldrich
1,6-己二醇, 99%
登录查看公司和协议定价
货号包装规格是否有货价格数量
25 μg
预计发货时间 2025年5月12日
详情...
¥1,527.90
200 μg
预计发货时间 2025年5月13日
详情...
¥9,037.64
Supelco
Discovery® Glycan SPE Tube, bed wt. 250 mg, volume 3 mL, pk of 54
登录查看公司和协议定价
货号包装规格是否有货价格数量
25 μg
预计发货时间 2025年5月12日
详情...
¥1,527.90
200 μg
预计发货时间 2025年5月13日
详情...
¥9,037.64
Supelco
Discovery® Glycan SPE Tube, bed wt. 500 mg, volume 6 mL, pk of 30
登录查看公司和协议定价
货号包装规格是否有货价格数量
25 μg
预计发货时间 2025年5月12日
详情...
¥1,527.90
200 μg
预计发货时间 2025年5月13日
详情...
¥9,037.64
Supelco
Discovery® Glycan SPE Bulk Packing, pkg of 50 g
登录查看公司和协议定价
货号包装规格是否有货价格数量
25 μg
预计发货时间 2025年5月12日
详情...
¥1,527.90
200 μg
预计发货时间 2025年5月13日
详情...
¥9,037.64
Supelco
Discovery® Glycan SPE Tube, bed wt. 1 g, volume 12 mL, pk of 20
登录查看公司和协议定价
货号包装规格是否有货价格数量
25 μg
预计发货时间 2025年5月12日
详情...
¥1,527.90
200 μg
预计发货时间 2025年5月13日
详情...
¥9,037.64
Supelco
Discovery® Glycan SPE Tube, 5 g, volume 60 mL, pk of 16
登录查看公司和协议定价
货号包装规格是否有货价格数量
25 μg
预计发货时间 2025年5月12日
详情...
¥1,527.90
200 μg
预计发货时间 2025年5月13日
详情...
¥9,037.64